World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
31138
World Ranking
9375
National Ranking
4834

Stephen B. Howell publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen B. Howell sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 430 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen B. Howell D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen B. Howell sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2015 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Stephen B. Howell is affiliated with the University of California, San Diego in the United States. Their research spans multiple areas in medicine, with significant outputs in biochemistry, genetics, and molecular biology. The scientist's work intersects several subfields including molecular biology, oncology, hematology, genetics, and immunology.

The primary topics explored in their research include:

  • Chronic Lymphocytic Leukemia Research
  • Immunotherapy and Immune Responses
  • Acute Myeloid Leukemia Research
  • Cancer Immunotherapy and Biomarkers
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Cancer Cells and Metastasis

Howell's publication record features articles in established scientific journals, particularly in cancer and hematology fields. Frequent venues for their research include:

  • Cancer Research
  • Blood
  • Journal of Translational Medicine
  • Bioconjugate Chemistry
  • PLoS ONE

Notable recent papers by Howell demonstrate a focus on cancer immunotherapy and molecular targets in hematologic malignancies and solid tumors. Selected papers include:

  • "Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer" (2020), Journal of Translational Medicine
  • "A Phase 1a/b Dose Escalation Study of the MYC Repressor Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS" (2021), Blood
  • "Therapeutic Targeting of Tumor Cells Rich in LGR Stem Cell Receptors" (2021), Bioconjugate Chemistry
  • "WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer" (2020), Anticancer Research
  • "Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia" (2022), Molecular Cancer Therapeutics

Collaborations have been an integral part of Howell's research endeavors, with frequent coauthors including William G. Rice, Nasrin Rastgoo, Rafael Bejar, Khalid Benbatoul, and Yuying Jin. These partnerships reflect interdisciplinary engagement within oncology and hematology research communities.

Stephen B. Howell was recognized in 2015 as a Fellow of the American Association for the Advancement of Science (AAAS), acknowledging contributions to the scientific field. Their continued research activity contributes to the understanding of molecular and therapeutic aspects of cancer and blood disorders.

Best Publications

  • The role of DNA mismatch repair in platinum drug resistance.

    Daniel Fink;Sibylle Nebel;Stefan Aebi;Hua Zheng

  • The role of DNA mismatch repair in drug resistance.

    Daniel Fink;Stefan Aebi;Stephen B. Howell

  • Loss of DNA mismatch repair in acquired resistance to cisplatin.

    S Aebi;B Kurdi-Haidar;R Gordon;B Cenni

  • Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells

    Roohangiz Safaei;Barrett J. Larson;Timothy C. Cheng;Michael A. Gibson

  • A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

    Michael J. Glantz;Michael J. Glantz;Kurt A. Jaeckle;Marc C. Chamberlain;Surasak Phuphanich

  • Intraperitoneal Cisplatin with Systemic Thiosulfate Protection

    Stephen B. Howell;Craig L. Pfeifle;Wally E. Wung;Richard A. Olshen

  • Mismatch repair proficiency and in vitro response to 5-fluorouracil

    John M. Carethers;Dharam P. Chauhan;Daniel Fink;Sibylle Nebel

  • Increased Expression of the Copper Efflux Transporter ATP7A Mediates Resistance to Cisplatin, Carboplatin, and Oxaliplatin in Ovarian Cancer Cells

    Goli Samimi;Roohangiz Safaei;Kuniyuki Katano;Alison K. Holzer

  • Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

    Michael J. Glantz;Suzanne LaFollette;Kurt A. Jaeckle;William Shapiro

  • Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin

    Alison K. Holzer;Gerald H. Manorek;Stephen B. Howell

  • Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.

    Kuniyuki Katano;Akira Kondo;Roohangiz Safaei;Alison Holzer

  • In Vitro and in Vivo Resistance to Cisplatin in Cells That Have Lost DNA Mismatch Repair

    Daniel Fink;Hua Zheng;Sibylle Nebel;Paula S. Norris

  • Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.

    Roohangiz Safaei;Stephen B. Howell

  • The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

    Xinjian Lin;Tsuyoshi Okuda;Alison Holzer;Stephen B. Howell

  • Porous Silicon Nanoparticle Photosensitizers for Singlet Oxygen and Their Phototoxicity Against Cancer Cells

    Ling Xiao;Luo Gu;Stephen B. Howell;Michael J. Sailor

  • The Copper Influx Transporter Human Copper Transport Protein 1 Regulates the Uptake of Cisplatin in Human Ovarian Carcinoma Cells

    Alison K Holzer;Goli Samimi;Kuniyuki Katano;Wiltrud Naerdemann

  • Long-Term Survival of Advanced Refractory Ovarian Carcinoma Patients with Small-Volume Disease Treated with Intraperitoneal Chemotherapy

    Stephen B. Howell;Soloman Zimm;Maurie Markman;Ian S. Abramson

  • Differential Potentiation of Alkylating and Platinating Agent Cytotoxicity in Human Ovarian Carcinoma Cells by Glutathione Depletion

    Paul A. Andrews;Michael P. Murphy;Stephen B. Howell

  • A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.

    Jeany M. Rademaker-Lakhai;Catherine Terret;Stephen B. Howell;Christiane M. Baud

  • Targeted chemoradiation for advanced head and neck cancer: Analysis of 213 patients

    K. Thomas Robbins;Parvesh Kumar;Frank S. H. Wong;William F. Hartsell

Frequent Co-Authors

Maurie Markman
Maurie Markman The University of Texas MD Anderson Cancer Center
Marc C. Chamberlain
Marc C. Chamberlain University of Washington
Michael J. Sailor
Michael J. Sailor University of California, San Diego
Nathan C. Gianneschi
Nathan C. Gianneschi Northwestern University
John Mendelsohn
John Mendelsohn The University of Texas at Austin
Paola Perego
Paola Perego University of Milan
Erkki Ruoslahti
Erkki Ruoslahti Sanford Burnham Prebys Medical Discovery Institute
Nissi M. Varki
Nissi M. Varki University of California, San Diego
Olivier Harismendy
Olivier Harismendy University of California, San Diego
Shannon K. McWeeney
Shannon K. McWeeney Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine isn’t limited to becoming a physician. There are many related online degrees that offer flexibility and strong job prospects in the growing healthcare sector.

If you’re interested in management and leadership roles in healthcare, a health administration degree can open doors to positions in hospitals, clinics, and health systems. For those aiming for advanced roles, the cheapest online mha programs provide a pathway to refine your expertise without the burden of high tuition.

Clinicians seeking to advance further may consider doctoral-level programs. The best online dnp programs support nurses looking to enter top clinical or administrative positions. Similarly, pharmacists can expand their qualifications through pharm d online programs, preparing them for advanced practice and research roles.

Pursuing these online degrees offers convenience, potential affordability, and the chance to tailor your career path while meeting the evolving demands of healthcare in the USA.

Best Scientists Citing Stephen B. Howell

Trending Scientists

Recently Published Articles